- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.12. | Arctic Bioscience AS: Financial calendar | 2 | Oslo Børs | ||
| 19.11. | Arctic Bioscience AS: Arctic Bioscience - Minutes of the Extraordinary General Meeting | 4 | Oslo Børs | ||
| 05.11. | ARCTIC BIOSCIENCE AS: Arctic Bioscience - Notice of Extraordinary General Meeting on 19 November 2024 | 1 | Cision News | ||
| 29.10. | ARCTIC BIOSCIENCE AS: Arctic Bioscience - Q3 2024 Operational update | 3 | Cision News | ||
| 16.10. | ARCTIC BIOSCIENCE AS: Arctic Bioscience - Presentation for today's webcast | 4 | Cision News | ||
| 15.10. | Arctic Bioscience AS: Arctic Bioscience - Mandatory notification of trade | 1 | Oslo Børs | ||
| 15.10. | Arctic Bioscience AS: Arctic Bioscience - Invitation to webcast - HeROPA read-out | 3 | Oslo Børs | ||
| ARCTIC BIOSCIENCE Aktie jetzt für 0€ handeln | |||||
| 14.10. | Arctic Bioscience AS: Arctic Bioscience - Announces top-line results from the phase 2b HeROPA study | 6 | Oslo Børs | ||
| 08.10. | Groupe Berkem & Arctic Bioscience Partner to Launch B-Romega: A Breakthrough in Omega-3 Innovation | 438 | Business Wire | GROUPE BERKEM ARCTIC BIOSCIENCE PARTNER TO LAUNCH B-ROMEGA: A BREAKTHROUGH IN OMEGA-3 INNOVATION The partnership introduces a breakthrough in Omega-3 supplements in North America Herring... ► Artikel lesen | |
| 25.09. | ARCTIC BIOSCIENCE AS: Arctic Bioscience - New cellular research showing anti-psoriatic effects | 3 | Cision News | ||
| 20.09. | Arctic Bioscience AS: Arctic Bioscience - Mandatory notification of trade | 1 | Oslo Børs | ||
| 29.08. | ARCTIC BIOSCIENCE AS: Arctic Bioscience - Study de-risked by all needed patients passed 6 months, read-out expected in 4-6 weeks | 2 | Cision News | ||
| 22.08. | ARCTIC BIOSCIENCE AS: Arctic Bioscience - Invitation to presentation of half year 2024 results | 2 | Cision News | ||
| 26.07. | Arctic Bioscience AS: Arctic Bioscience - Mandatory notification of trade | - | Oslo Børs |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS | 7,270 | +4,01 % | Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules | Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. ("Recursion") (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug... ► Artikel lesen | |
| TEMPUS AI | 34,650 | -0,74 % | Tempus AI (NASDAQ:TEM) Shares Down 5.7% Following Insider Selling | ||
| SUMMIT THERAPEUTICS | 18,940 | +1,45 % | Where Will Summit Therapeutics Be in 5 Years? | ||
| ADMA BIOLOGICS | 17,390 | -1,86 % | ADMA Biologics, Inc.: ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility | ||
| EDGEWISE THERAPEUTICS | 29,660 | -1,07 % | Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains | ||
| 180 LIFE SCIENCES | 2,740 | +46,52 % | 180 Life Sciences Corp. - S-1/A, General form for registration of securities | ||
| JANUX THERAPEUTICS | 56,13 | -1,09 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 36,810 | -1,50 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | - Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors... ► Artikel lesen | |
| ARS PHARMACEUTICALS | 11,450 | +2,23 % | ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Announces neffy (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies | ||
| ARCUTIS BIOTHERAPEUTICS | 14,980 | +0,07 % | Arcutis Biotherapeutics, Inc.: Arcutis Submits ZORYVE (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis | ZORYVE cream 0.05% provided meaningful disease clearance and rapid reduction in itch in pivotal trialsRoflumilast cream was well tolerated and demonstrated a favorable safety and tolerability profile... ► Artikel lesen | |
| NUVALENT | 82,83 | -1,22 % | Nuvalent-CEO Porter James Richard verkauft Aktien im Wert von 2,34 Millionen US-Dollar | ||
| ARCELLX | 77,10 | +0,40 % | Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer... ► Artikel lesen | |
| ALPHA TEKNOVA | 8,615 | +12,17 % | Alpha Teknova Stock Hits 52-Week High at $8.93 Amid Growth Surge | ||
| NEUMORA THERAPEUTICS | 10,745 | -3,37 % | Neumora Therapeutics (NASDAQ:NMRA) Shares Down 3% - Should You Sell? | ||
| HUMACYTE | 4,525 | -2,69 % | Pre-market Movers: My Size, Nvni Group, Psyence Biomedical, Humacyte, PainReform | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.55 A.M. ET).In the Green My Size, Inc. (MYSZ) is up over 372% at $6.43.
Nvni... ► Artikel lesen |
ARCTIC BIOSCIENCE AS gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,137 Euro und damit +2,24 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ARCTIC BIOSCIENCE AS finden Sie auf Wallstreet Online.
